Indianapolis, IN, United States of America

Stephen W Kaldor

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 284(Granted Patents)


Company Filing History:


Years Active: 1995-2004

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: Stephen W. Kaldor: A Pioneer in Pharmaceutical Innovations

Introduction

Stephen W. Kaldor is a notable inventor based in Indianapolis, IN, with an impressive portfolio of 30 patents to his name. His work primarily focuses on developing innovative solutions within the pharmaceutical industry, which has had a significant impact on health and wellness.

Latest Patents

Among his most recent patents are groundbreaking intellectual properties such as a method of making HIV protease inhibitors and non-peptidyl vasopressin V1A antagonists. These inventions exhibit Kaldor's commitment to addressing critical medical challenges and enhancing therapeutic options.

Career Highlights

Stephen has had a distinguished career, working with prominent companies such as Eli Lilly and Company and Agouron Pharmaceuticals, Inc. During his time at these organizations, he was heavily involved in research and development efforts that brought innovative pharmaceutical products to market, showcasing his expertise in drug formulation and design.

Collaborations

Throughout his career, Stephen Kaldor has collaborated with esteemed colleagues, including James E. Fritz and Bruce Anthony Dressman. These partnerships have contributed to the advancement of numerous projects and have fostered a collaborative spirit in the pursuit of innovation in the pharmaceutical field.

Conclusion

Stephen W. Kaldor's contributions to the field of pharmaceuticals, highlighted by his 30 patents and collaborations with industry-leading professionals, mark him as a pioneer in innovation. His work continues to influence the way healthcare challenges are approached, making a meaningful difference in the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…